Oral Prednisone Speeds Uveitis Inflammation Control

Adults with HLA-B27-associated acute anterior uveitis may recover inflammation control faster with added oral steroids, though the study was retrospective.

Updated on Nov. 4, 2026 in Arthritis

Photograph of a white ophthalmic instrument with a stainless-steel arm beside a small amber dropper bottle on a pale surface under soft daylight. — A retrospective study of 462 patients published November 2 in the American Journal of Ophthalmology found added oral prednisone linked to faster control of eye inflammation. AI Illustration. Upload story photo >

A retrospective study of 462 patients with HLA-B27-associated acute anterior uveitis found that adding oral prednisone to topical corticosteroid eye drops was linked to faster control of eye inflammation, though time to stopping all corticosteroids was similar with or without prednisone. The study was published online November 2, 2026, in the American Journal of Ophthalmology, and is most relevant to adults with this form of uveitis.

Why it matters

Acute anterior uveitis is a painful inflammation of the front of the eye, and HLA-B27-associated cases are a common form of it. The findings give clinicians real-world data on how quickly patients recovered with different treatment combinations, which may help inform decisions about how aggressively to treat flare-ups.

This retrospective study reviewed one eye each of 462 patients with HLA-B27-associated acute anterior uveitis seen from 2014 to 2025, with a median age of 42 years. Adding oral prednisone to topical corticosteroids was associated with faster inflammation control (median 28 days vs. 41 days with drops alone), though the study design cannot establish cause and effect.

The players

Bascom Palmer Eye Institute

A Miami-based eye care center and research institution affiliated with the University of Miami, known for research and clinical care in ophthalmology, including inflammatory eye diseases such as uveitis.

American Journal of Ophthalmology

A peer-reviewed medical journal that publishes clinical and laboratory research across eye care, including studies on inflammatory eye conditions.

The details

Acute anterior uveitis is inflammation of the iris and front structures of the eye, and it is typically first treated with topical corticosteroid drops that calm the immune response in the eye. In this study, 93% of patients were initially managed in the emergency department, and 74 patients also received oral prednisone, usually a median starting dose of 60 mg, about nine days after presentation. Prednisone was mostly added when inflammation had not improved or had worsened on drops, so the two groups differed in how severe their disease was at the outset.

Patients in the study were seen between 2014 and 2025.
The study was published online on November 2, 2026.

Health Landscape

Topical corticosteroids remain the standard first-line treatment for acute anterior uveitis, and oral corticosteroids are generally reserved for more severe or non-responding cases. This study adds population-level evidence to the question of when escalation to oral therapy may be warranted, a debate that is active across ophthalmology.

If you have experienced painful eye redness, light sensitivity, or blurred vision, these symptoms warrant prompt evaluation, since uveitis can be serious if untreated. Anyone with a history of HLA-B27-associated inflammation, such as those with inflammatory arthritis, may want to ask their eye doctor about treatment options worth discussing.

The takeaway

Early and appropriate treatment of uveitis can help control inflammation faster, and this study suggests adding short-course oral prednisone may help some patients. Anyone with sudden eye pain or redness should see an eye doctor promptly, and any decision about oral steroids should be made with a physician.